JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Currency

Home
Our products
Resources
- Scientific publicationsNew discoveries, research findings, and advancements in various areas of study
- Technical notesPerformance and technical support to aid product comparisons
- Flyers & applicationsShort form promotional materials to inform on product information
- Product catalogsComprehensive listings showcasing product ordering information
- FAQsFrequently asked questions
About us
- Our scienceCapabilities and areas of expertise
- Our certificationsReview our ISO certifications and quality documents
- Join the teamLearn more about open opportunities
- SustainabilityOur efforts towards securing a sustainable future
News
- Articles & press releasesRegularly published news and articles
- Events & webinarsUp to date information on exciting and upcoming events

Serum - Mild Cognitive Impairment

Datasheet

Catalog Number: 991-24-S-MCI

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Key Features

Form :

Liquid

SKU Price(USD) Size Qty

991-24-S-MCI-1 $322.88 1 x 1 mL

Qty:

+ -

991-24-S-MCI-5 $1,373.50 5 x 1 mL

Qty:

+ -

991-24-S-MCI-20 $4,612.50 20 x 1 mL

Qty:

+ -

991-24-S-MCI-50 $10,147.50 50 x 1 mL

Qty:

+ -

Custom Quote

Bulk or bespoke? We IVDo that
Request a call back
to discuss your information requirements

Product Overview

Product Name	Serum - Mild Cognitive Impairment
Catalog Number	991-24-S-MCI
Description	Mild Cognitive Impairment Serum Samples
Alternative Names	(click to expand) MCI, Dementia

Further Specification

Form/Appearance	Liquid
Preservatives	None
Source	Single Human Donor
Unit Definition	1 donor x >/=1mL: each sample is from a unique donor

Storage and Shipping

Storage	-20°C
Shipping	Dry Ice
Shelf Life	Due to differing stabilities of various biomarkers in this complex biological material it is not possible to assign a single expiration date that is relevant to all biomarkers. The end user should monitor the biomarkers of interest to verify suitability over time.